[The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency].
Zakharov
V V
VV
Lokshina
A B
AB
Stakhovskaia
L V
LV
Timerbaeva
S L
SL
Lagoda
O V
OV
D000368:Aged; D000369:Aged, 80 and over; D002121:Calcium Channel Blockers; D002561:Cerebrovascular Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003071:Cognition / Q000187:drug effects / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018697:Nootropic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D010889:Piracetam / Q000008:administration & dosage / Q000627:therapeutic use*; D011594:Psychometrics / Q000379:methods; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014748:Vinca Alkaloids / Q000008:administration & dosage / Q000627:therapeutic use*
D002121:Calcium Channel Blockers; D004338:Drug Combinations; D018697:Nootropic Agents; D014665:Vasodilator Agents; D014748:Vinca Alkaloids; C013983:vinpocetine; D010889:Piracetam